These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 426139)

  • 21. Reduction of blood platelet serotonin levels in manic and depressed patients.
    Takahashi S
    Folia Psychiatr Neurol Jpn; 1976; 30(4):476-86. PubMed ID: 1087914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and biochemical contributions on the action of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 13(3):164-72. PubMed ID: 93762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of 3-methoxy-4-hydroxyphenyethylene-glycol and its urinary conjugates. Value in the diagnosis and therapeutic follow-up of depression].
    Tapie M; Garnier JP; Tremine T; Bousquet B; Manet L; Dreux C; Lauzel JP
    Pathol Biol (Paris); 1988 Mar; 36(3):217-23. PubMed ID: 2452402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of tryptophan in depressive disease.
    Frazer A; Pandey GN; Mendels J
    Arch Gen Psychiatry; 1973 Oct; 29(4):528-35. PubMed ID: 4748313
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical characteristics of unipolar and bipolar depression].
    Cvjetković-Bosnjak M
    Med Pregl; 1998; 51(7-8):329-32. PubMed ID: 9769667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysfunctional attitudes and cognitive schemas in bipolar manic and unipolar depressed outpatients: implications for cognitively based psychotherapeutics.
    Goldberg JF; Gerstein RK; Wenze SJ; Welker TM; Beck AT
    J Nerv Ment Dis; 2008 Mar; 196(3):207-10. PubMed ID: 18340255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up.
    Goldberg JF; Harrow M
    J Affect Disord; 2004 Aug; 81(2):123-31. PubMed ID: 15306137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations.
    Sacchetti E; Allaria E; Negri F; Biondi PA; Smeraldi E; Cazzullo CL
    Biol Psychiatry; 1979 Jun; 14(3):473-84. PubMed ID: 476232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.
    Mooney JJ; Schatzberg AF; Cole JO; Samson JA; Waternaux C; Gerson B; Pappalardo KM; Schildkraut JJ
    J Clin Psychopharmacol; 1991 Dec; 11(6):339-43. PubMed ID: 1770151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indoleamine metabolism in affective disorders: excretion of tryptamine, indoleacetic acid and 5-hydroxy-indoleacetic acid in depressive states.
    McNamee HB; Moody JP; Naylor GJ
    J Psychosom Res; 1972 Feb; 16(1):63-70. PubMed ID: 5058989
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary metabolites of tryptophan, serotonin and norepinephrine in alcoholics.
    Akhter MI; Clark PM; Kricka LJ; Nicholson G
    J Stud Alcohol; 1978 May; 39(5):833-41. PubMed ID: 672222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total and free plasma tryptophan levels in patients with affective disorders: effects of a peripheral decarboxylase inhibitor.
    Garfinkel PE; Warsh JJ; Stancer HC; Sibony D
    Arch Gen Psychiatry; 1976 Dec; 33(12):1462-6. PubMed ID: 999449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of inhibition of serotonin synthesis on 5-hydroxyindoleacetic acid excretion, in healthy subjects.
    Alfieri AB; Cubeddu LX
    J Clin Pharmacol; 1994 Feb; 34(2):153-7. PubMed ID: 7512997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease.
    Sekiduka-Kumano T; Kawayama T; Ito K; Shoji Y; Matsunaga K; Okamoto M; Edakuni N; Imaoka H; Uchimura N; Hoshino T
    BMC Psychiatry; 2013 May; 13():159. PubMed ID: 23721166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of circadian MHPG rhythmicity in major depression.
    Piletz JE; DeMet E; Gwirtsman HE; Halaris A
    Biol Psychiatry; 1994 Jun; 35(11):830-42. PubMed ID: 8054405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary levels of 3-methoxy-4-hydroxyphenylglycol predict symptom severity in selected patients with unipolar depression.
    Garvey MJ; Tuason VB
    Psychiatry Res; 1996 May; 62(2):171-7. PubMed ID: 8771614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical, biochemical and psychopharmacologic correlates in patients with depressive symptomatology].
    Martín JL; Spatz H; Abdala NE; Basombrio J
    Acta Psiquiatr Psicol Am Lat; 1980 Mar; 26(1):13-25. PubMed ID: 6182756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3-methoxy-4-hydroxyphenylglycol (MHPG)].
    Yoneda M; Sanada H
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():404-6. PubMed ID: 16149540
    [No Abstract]   [Full Text] [Related]  

  • 39. Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient.
    Post RM; Stoddard FJ; Gillin JC; Buchsbaum MS; Runkle DC; Black KE; Bunney WE
    Arch Gen Psychiatry; 1977 Apr; 34(4):470-7. PubMed ID: 192169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicompartmental analysis of amino acid. 1. Preliminary data on concentrations, fluxes, and flow constants of tryptophan in affective illness.
    Shaw DM; Johnson AL; Tidmarsh ; Macsweeney DA; Hewland HR; Woolcock NE
    Psychol Med; 1975 May; 5(2):206-13. PubMed ID: 1161958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.